| Omicron variant of SARS-CoV-2: An Indian perspective of vaccination and management VP Chavda, P Balar, D Vaghela, HK Solanki, A Vaishnav, V Hala, L Vora Vaccines 11 (1), 160, 2023 | 38 | 2023 |
| Nasal sprays for treating COVID-19: a scientific note VP Chavda, KP Baviskar, DA Vaghela, SS Raut, AP Bedse Pharmacological Reports 75 (2), 249-265, 2023 | 28 | 2023 |
| Potential anti-SARS-CoV-2 prodrugs activated by phosphorylation and their role in the aged population VP Chavda, D Teli, PC Balar, D Vaghela, HK Solanki, A Vaishnav, L Vora Molecules 28 (5), 2332, 2023 | 18 | 2023 |
| Parenteral microemulsions for drug delivery: Advances and update VP Chavda, NR Gogoi, DA Vaghela, PC Balar, S Dawre, DJ Dave Journal of Drug Delivery Science and Technology 89, 104991, 2023 | 13 | 2023 |
| Post-COVID-19 fungal infection in the aged population VP Chavda, T Mishra, S Kamaraj, S Punetha, O Sengupta, Y Joshi, ... Vaccines 11 (3), 555, 2023 | 13 | 2023 |
| Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes V Chavda, KK Zajac, JL Gunn, P Balar, A Khadela, D Vaghela, S Soni, ... Cancer Reports 6, e1821, 2023 | 12 | 2023 |
| Nanoemulsions: summary of a decade of research and recent advances VP Chavda, PC Balar, R Bezbaruah, DA Vaghela, D Rynjah, ... Nanomedicine 19 (6), 519-536, 2024 | 9 | 2024 |
| Combatting infectious diarrhea: innovations in treatment and vaccination strategies VP Chavda, S Vuppu, T Mishra, S Kamaraj, N Sharma, S Punetha, ... Expert Review of Vaccines 23 (1), 246-265, 2024 | 7 | 2024 |
| A Review on Pharmacological Activities of Polyalthia longifolia L D Vaghela, D Pandya, H Solanki EPRA Int J Res Dev 6 (2), 172-177, 2021 | 5 | 2021 |
| R: An open source software environment for statistical analysis Y PATEL, D VAGHELA, H SOLANKI, M Vaidya Inflibnet24, 14-21, 2017 | 5 | 2017 |
| Unlocking longevity with GLP-1: A key to turn back the clock? VP Chavda, PC Balar, DA Vaghela, P Dodiya Maturitas, 108028, 2024 | 4 | 2024 |
| Self-assembled peptide hydrogels for the treatment of diabetes and associated complications VP Chavda, D Teli, PC Balar, M Davidson, J Bojarska, DA Vaghela, ... Colloids and Surfaces B: Biointerfaces 235, 113761, 2024 | 4 | 2024 |
| Reviving Fertility: Phytochemicals as Natural Allies in the Fight against Non-genetic Male Infertility VP Chavda, SS Sonak, PC Balar, K Vyas, P Palandurkar, K Mule, K Patel, ... Clinical Complementary Medicine and Pharmacology 4 (1), 100128, 2024 | 2 | 2024 |
| Nanosuspensions: A New Era of Targeted Therapeutics VP Chvada, DA Vaghela, HK Solanki, PC Balar, S Modi, NR Gogoi Journal of Drug Delivery Science and Technology, 106613, 2025 | | 2025 |
| Theranostics polylactic-co-glycolic acid nanoparticles mediated drug delivery VP Chavda, PC Balar, R Bezbaruah, DA Vaghela, K Vyas Theranostics Nanomaterials in Drug Delivery, 133-155, 2025 | | 2025 |
| Nanovaccine via Intramuscular, Subcutaneous, and Intradermal Routes DA Vaghela, MB Pandya, PM Parmar, SP Chauhan, A Vaishnav, RK Patel, ... Nanocarrier Vaccines: Biopharmaceutics‐Based Fast Track Development, 405-422, 2024 | | 2024 |
| Plant-Derived Exosomes in Therapeutic Nanomedicine, Paving the Path Toward Precision Medicine M Zheng, VP Chavda, DA Vaghela, R Bezbaruah, NR Gogoi, K Patel, ... Phytomedicine, 156087, 2024 | | 2024 |
| Extracellular Vesicles and Cardiovascular Disease: Diagnostic and Therapeutic Perspective VP Chavda, PC Balar, DA Vaghela, H Jani, LV Nalla, J Vitore Extracellular Vesicles in Human Health and Diseases, 255-287, 2024 | | 2024 |
| Nasal Vaccine for the Control of Emerging Variants of SARS-CoV-2 A Kumar, DA Vaghela, PC Balar, K Bhavisker, R Bezbaruah, L Nongrang, ... SARS-CoV-2 Variants and Global Population Vulnerability, 249-283, 2024 | | 2024 |
| Andrographolide: A Review on Experimental Clinical Trials and Applications D Teli, DA Vaghela, A Chaudhri, HK Solanki, K Jetha, VP Chavda Journal of Experimental and Clinical Application of Chinese Medicine, 55-72, 2024 | | 2024 |
Vivek P ChavdaAsst. Professor, L.M. College of Pharmacy, AhmedabadEmail verificata su lmcp.ac.in